1 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Semaglutide 2.4mg: new trials by email Literature Review of Semaglutide 2.4mg trials Research Report on Semaglutide 2.4mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide Treatment in Type 1 Diabetes Semaglutide 2.4mg, Semaglutide placebo - Obesity in Diabetes, Obesity/Therapy | Phase 3 | Not yet recruiting | Nordsjaellands Hospital | 122 | 2025-10-01 | 2025-08-08 |
| Semaglutide for Post-Smoking Cessation Weight Management semaglutide 2.4mg, Placebo, Nicotine Replacement Therapy (NRT, nicotine patch) - Obesity, Overweight | Phase 2 | Recruiting | The University of Texas Health Science Center, Houston | 197 | 2024-04-23 | 2026-09-21 |
| Latino Semaglutide Study Semaglutide 2.4mg, Placebo - Obesity, Obesity; Drug | Phase 3 | Completed | Loma Linda University | 119 | 2022-12-13 | 2024-10-15 |
Obesity (3) · Overweight (2) · Weight Loss (2) · Body Weight (1) · Body-Weight Trajectory (1) · Cigarette Smoking (1) · Diabetes Mellitus, Type 1 (1) · Insulin Resistance (1) · Smoking (1)
Loma Linda University (1) · Nordsjaellands Hospital (1) · The University of Texas Health Science Center, Houston (1)
United States (2) · Denmark (1)
Luba Yammine, PhD (1) · Thomas F Dejgaard, MD, ph.d., endocrinologist (1) · Warren Peters, MD (1)